171 related articles for article (PubMed ID: 15869718)
1. Practical guide to the management of osteoporosis in men with prostate cancer receiving androgen-deprivation therapy.
Bruder JM
Curr Urol Rep; 2005 May; 6(3):157-8. PubMed ID: 15869718
[No Abstract] [Full Text] [Related]
2. Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer.
Smith MR
Drugs Aging; 2003; 20(3):175-83. PubMed ID: 12578398
[TBL] [Abstract][Full Text] [Related]
3. Calcium supplements in patients with prostate cancer.
Molokwu CN
BJU Int; 2007 Dec; 100(6):1411. PubMed ID: 17979937
[No Abstract] [Full Text] [Related]
4. Osteoporosis from androgen deprivation therapy in prostate cancer treatment.
McLeod N; Huynh CC; Rashid P
Aust Fam Physician; 2006 Apr; 35(4):243-5. PubMed ID: 16642243
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates in prostate cancer: where are we and where should we go?
Saad F
J Natl Cancer Inst; 2003 Sep; 95(17):1262-3. PubMed ID: 12953073
[No Abstract] [Full Text] [Related]
6. The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.
Smith MR
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):21-5. PubMed ID: 15202584
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis and prostate cancer.
Dhillon T; Waxman J
Br J Cancer; 2003 Sep; 89(5):779-80. PubMed ID: 12942104
[No Abstract] [Full Text] [Related]
8. Approach to the prostate cancer patient with bone disease.
Greenspan SL
J Clin Endocrinol Metab; 2008 Jan; 93(1):2-7. PubMed ID: 18178905
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of osteoporosis--important for the urologist?].
Lümmen G; Rübben H; Schneider T; Sperling H
Urologe A; 2007 Jun; 46(6):651-5. PubMed ID: 17453170
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
[No Abstract] [Full Text] [Related]
11. [Prevention of bone loss in a patient receiving androgen deprivation therapy].
Rolfes N; Lümmen G
Urologe A; 2011 Nov; 50(11):1383-6. PubMed ID: 21800195
[TBL] [Abstract][Full Text] [Related]
12. Nursing implications of androgen deprivation therapy-associated bone loss.
Weingard KK
Urol Nurs; 2006 Aug; 26(4):261-9; quiz 270. PubMed ID: 16939043
[TBL] [Abstract][Full Text] [Related]
13. Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate.
Magno C; Anastasi G; Morabito N; Gaudio A; Maisano D; Franchina F; Galì A; Frisina N; Melloni D
Eur Urol; 2005 May; 47(5):575-80; discussion 580-1. PubMed ID: 15826746
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation in prostate cancer and the long-term risk of fracture.
Ojeda S; Lloret M; Naranjo A; Déniz F; Chesa N; Domínguez C; Lara PC
Actas Urol Esp; 2017 Oct; 41(8):491-496. PubMed ID: 28259363
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: Bone density testing--essential or extraneous?
Yu EY
Nat Rev Urol; 2013 Jan; 10(1):11-2. PubMed ID: 23229500
[No Abstract] [Full Text] [Related]
16. Influence of insolation on osteoporosis progression in androgen deprived nonmetastatic prostate cancer patients.
Spanjol J; Maricić A; Valencić M; Oguić R; Krpina K; Protić A; Ivancić A; Bobinac M; Fuckar D; Vojniković B
Coll Antropol; 2008 Oct; 32 Suppl 2():79-81. PubMed ID: 19138011
[TBL] [Abstract][Full Text] [Related]
17. Effect of Diphosphonates on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
Wu C; Chen W; Huang X; Lin R; Wu J; Zhang X
Clin Genitourin Cancer; 2018 Dec; 16(6):e1243-e1250. PubMed ID: 30146230
[TBL] [Abstract][Full Text] [Related]
18. Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.
Grossmann M; Hamilton EJ; Gilfillan C; Bolton D; Joon DL; Zajac JD
Med J Aust; 2011 Mar; 194(6):301-6. PubMed ID: 21426285
[TBL] [Abstract][Full Text] [Related]
19. Screening for osteoporosis in men receiving androgen deprivation therapy.
Alibhai SM; Yun L; Cheung AM; Paszat L
JAMA; 2012 Jan; 307(3):255-6. PubMed ID: 22253389
[No Abstract] [Full Text] [Related]
20. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.
Ross RW; Small EJ
J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
